abstract |
Methods for treating conditions associated with Αβ peptide activity are described both prophylactically and therapeutically. The method uses a humanized antibody fragment that specifically binds between amino acid positions 13-28 of the human Αβ peptide, wherein the antibody fragment is covalently linked to a polyethylene glycol (PEG) molecule. |